1. Academic Validation
  2. Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death

Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death

  • Nature. 2003 Feb 6;421(6923):634-9. doi: 10.1038/nature01335.
Peter J Mohler 1 Jean-Jacques Schott Anthony O Gramolini Keith W Dilly Silvia Guatimosim William H duBell Long-Sheng Song Karine Haurogné Florence Kyndt Mervat E Ali Terry B Rogers W J Lederer Denis Escande Herve Le Marec Vann Bennett
Affiliations

Affiliation

  • 1 Howard Hughes Medical Institute and Departments of Cell Biology, Biochemistry, and Neuroscience, Duke University Medical Center, Durham, North Carolina 27710, USA.
Abstract

Mutations in ion channels involved in the generation and termination of action potentials constitute a family of molecular defects that underlie fatal cardiac arrhythmias in inherited long-QT syndrome. We report here that a loss-of-function (E1425G) mutation in ankyrin-B (also known as ankyrin 2), a member of a family of versatile membrane adapters, causes dominantly inherited type 4 long-QT cardiac arrhythmia in humans. Mice heterozygous for a null mutation in ankyrin-B are haploinsufficient and display arrhythmia similar to humans. Mutation of ankyrin-B results in disruption in the cellular organization of the sodium pump, the sodium/calcium exchanger, and inositol-1,4,5-trisphosphate receptors (all ankyrin-B-binding proteins), which reduces the targeting of these proteins to the transverse tubules as well as reducing overall protein level. Ankyrin-B mutation also leads to altered Ca2+ signalling in adult cardiomyocytes that results in extrasystoles, and provides a rationale for the arrhythmia. Thus, we identify a new mechanism for cardiac arrhythmia due to abnormal coordination of multiple functionally related ion channels and transporters.

Figures